A detailed history of Massachusetts Financial Services CO transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, Massachusetts Financial Services CO holds 476,505 shares of PRCT stock, worth $30.3 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
476,505
Previous 571,583 16.63%
Holding current value
$30.3 Million
Previous $24 Million 1.7%
% of portfolio
0.01%
Previous 0.01%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$40.38 - $50.75 $3.84 Million - $4.83 Million
-95,078 Reduced 16.63%
476,505 $23.5 Million
Q4 2023

Feb 08, 2024

SELL
$24.89 - $43.41 $2.65 Million - $4.62 Million
-106,444 Reduced 15.7%
571,583 $24 Million
Q3 2023

Nov 08, 2023

BUY
$30.02 - $38.81 $34,673 - $44,825
1,155 Added 0.17%
678,027 $22.2 Million
Q2 2023

Aug 09, 2023

BUY
$26.7 - $37.02 $3.59 Million - $4.98 Million
134,554 Added 24.81%
676,872 $23.9 Million
Q1 2023

May 10, 2023

BUY
$26.64 - $39.74 $4.7 Million - $7.02 Million
176,549 Added 48.27%
542,318 $15.4 Million
Q4 2022

Feb 13, 2023

BUY
$38.78 - $46.78 $45,372 - $54,732
1,170 Added 0.32%
365,769 $15.2 Million
Q3 2022

Nov 09, 2022

BUY
$30.9 - $50.65 $774,354 - $1.27 Million
25,060 Added 7.38%
364,599 $15.1 Million
Q2 2022

Aug 09, 2022

SELL
$29.23 - $44.45 $14.2 Million - $21.5 Million
-484,705 Reduced 58.81%
339,539 $11.1 Million
Q1 2022

May 11, 2022

BUY
$16.89 - $35.74 $4.87 Million - $10.3 Million
288,268 Added 53.78%
824,244 $28.8 Million
Q4 2021

Feb 10, 2022

BUY
$24.6 - $46.29 $3.08 Million - $5.79 Million
125,010 Added 30.42%
535,976 $13.4 Million
Q3 2021

Nov 10, 2021

BUY
$35.91 - $41.94 $14.8 Million - $17.2 Million
410,966 New
410,966 $15.7 Million

Others Institutions Holding PRCT

About PROCEPT BioRobotics Corp


  • Ticker PRCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 44,592,300
  • Market Cap $2.84B
  • Description
  • PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...
More about PRCT
Track This Portfolio

Track Massachusetts Financial Services CO Portfolio

Follow Massachusetts Financial Services CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Massachusetts Financial Services CO , based on Form 13F filings with the SEC.

News

Stay updated on Massachusetts Financial Services CO with notifications on news.